G9a Regulates Cell Sensitivity to Radiotherapy via Histone H3 Lysine 9 Trimethylation and CCDC8 in Lung Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Ma L, Qiu B, Zhang J, et al. Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy. Chin J Cancer. 2017;36(1):93. doi:10.1186/s40880-017-0261-0
   PubMedGoogle Scholar
• Hu X, Bao Y, Xu Y, et al. Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses. Cancer. 2020;126(4):840–849. doi:10.1002/cncr.32586
   PubMed Web of Science ®Google Scholar
• Jiang G, Zhang X, Zhang Y, et al. Coiled-coil domain-containing protein 8 inhibits the invasiveness and migration of non-small cell lung cancer cells. Hum Pathol. 2016;56:64–73. doi:10.1016/j.humpath.2016.06.001
   PubMed Web of Science ®Google Scholar
• Pan ZQ. Cullin-RING E3 Ubiquitin Ligase 7 in Growth Control and Cancer. Adv Exp Med Biol. 2020;1217:285–296. doi:10.1007/978-981-15-1025-0_17
   Google Scholar
• Nakagawa T, Sato Y, Tanahashi T, et al. JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8. Gastric Cancer. 2020;23(3):426–436. doi:10.1007/s10120-019-01024-9
   PubMed Web of Science ®Google Scholar
• Smits K, Melotte V, Niessen H, et al. Epigenetics in radiotherapy: where are we heading? Radiother Oncol. 2014;111(2):168–177. doi:10.1016/j.radonc.2014.05.001
   PubMed Web of Science ®Google Scholar
• Xiang M, Liu W, Tian W, You A, Deng D. RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy. Epigenomics. 2020;12(9):801–809. doi:10.2217/epi-2019-0358
   PubMed Web of Science ®Google Scholar
• Zhu X, Wang Y, Tan L, Fu X. The pivotal role of DNA methylation in the radio-sensitivity of tumor radiotherapy. Cancer Med. 2018;7(8):3812–3819. doi:10.1002/cam4.1614
   PubMed Web of Science ®Google Scholar
• Kim M, Kim M, Kim W, et al. Suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation and histone deacetylation and regulate response to radiotherapy in cervical cancer cells. PLoS One. 2015;10(4):e0123133. doi:10.1371/journal.pone.0123133
   PubMed Web of Science ®Google Scholar
• Rowbotham S, Li F, Dost A, et al. H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression. Nat Commun. 2018;9(1):4559. doi:10.1038/s41467-018-07077-1
   PubMedGoogle Scholar
• Chen M, Hua K, Kao H, et al. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res. 2010;70(20):7830–7840. doi:10.1158/0008-5472.can-10-0833
   PubMed Web of Science ®Google Scholar
• Dang N, Jiao J, Meng X, An Y, Han C, Huang S. Abnormal overexpression of G9a in melanoma cells promotes cancer progression via upregulation of the Notch1 signaling pathway. Aging. 2020;12(3):2393–2407. doi:10.18632/aging.102750
   PubMedGoogle Scholar
• Tu W, Shiah Y, Lourenco C, et al. MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis. Cancer Cell. 2018;34(4):579–595.e8. doi:10.1016/j.ccell.2018.09.001
   PubMed Web of Science ®Google Scholar
• Lai Y, Chen J, Tsai H, Chen T, Hung W. The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells. Blood Cancer J. 2015;5(5):e313. doi:10.1038/bcj.2015.37
   PubMedGoogle Scholar
• Pangeni R, Channathodiyil P, Huen D, et al. The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain. Clin Epigenetics. 2015;7(1):57. doi:10.1186/s13148-015-0089-x
   PubMedGoogle Scholar
• Lu T, Chen D, Wang Y, et al. Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas. Cancer Cell Int. 2019;19(1):52. doi:10.1186/s12935-019-0770-9
   PubMedGoogle Scholar
• Nagaraja S, Subramanian U, Nagarajan D. Radiation-induced H3K9 methylation on E-cadherin promoter mediated by ROS/Snail axis: role of G9a signaling during lung epithelial-mesenchymal transition. Toxicol in Vitro. 2021;70:105037. doi:10.1016/j.tiv.2020.105037
   PubMed Web of Science ®Google Scholar
• Morris M, Ricketts C, Gentle D, et al. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene. 2011;30(12):1390–1401. doi:10.1038/onc.2010.525
   PubMed Web of Science ®Google Scholar
• Cao Y, Sun J, Li M, et al. Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells. Acta Pharmacol Sin. 2019;40(8):1076–1084. doi:10.1038/s41401-018-0205-5
   PubMed Web of Science ®Google Scholar
• Yin C, Ke X, Zhang R, et al. G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR. FASEB J. 2019;33(12):14036–14050. doi:10.1096/fj.201900233RR
   PubMed Web of Science ®Google Scholar
• Luo C, Wang J, Hung W, et al. G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response. Radiother Oncol. 2017;124(3):395–402. doi:10.1016/j.radonc.2017.03.002
   PubMed Web of Science ®Google Scholar
• Pan M, Hsu M, Luo C, Chen L, Shan Y, Hung W. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer. Oncotarget. 2016;7(38):61136–61151. doi:10.18632/oncotarget.11256
   PubMed Web of Science ®Google Scholar
• Crawford N, McIntyre A, McCormick A, D’Costa Z, Buckley N, Mullan P. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells. Oncogene. 2019;38(31):5971–5986. doi:10.1038/s41388-019-0853-z
   PubMed Web of Science ®Google Scholar
• Guo A, Huang Y, Ma X, Lin R. Mechanism of G9a inhibitor BIX‑01294 acting on U251 glioma cells. Mol Med Rep. 2016;14(5):4613–4621. doi:10.3892/mmr.2016.5815
   PubMed Web of Science ®Google Scholar
• Paschall A, Yang D, Lu C, et al. H3K9 trimethylation silences fas expression to confer colon carcinoma immune escape and 5-fluorouracil chemoresistance. J Immunol. 2015;195(4):1868–1882. doi:10.4049/jimmunol.1402243
   PubMed Web of Science ®Google Scholar